Sai Balaji Andugulapati

20PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Biologically active moleculesMolecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 14, 2026
Ligand-Engineered Cu(II) Complexes Suppress Stemness and Drug Resistance in Triple-Negative Breast Cancer.

|Jul 03, 2026
Red-Light-Triggered In Vitro and In Vivo Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

|May 26, 2026
Targeting mTOR with vistusertib attenuates metabolic steatohepatitis and prevents HCC development.

|May 15, 2026
Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti-Inflammatory Agents.

|May 14, 2026
Structure-Guided Discovery of a Bis-Pyridyl Diamine-Based Dual CDK7/9 Inhibitor with In Vitro and In Vivo Antitumor Efficacy in Glioblastoma Multiforme.

|Mar 19, 2026
Mavacamten Derivatives Significantly Ameliorate Lipopolysaccharide-Induced Acute Lung Injury, Partly by Modulating Nuclear Factor Kappa‑B Signaling.

Anjali Veeram, Rahul Shingare, Nithya Sree Pr

Pageof 4

Frequent Collaborators

3 joint publications

Tukki Sarkar

3 joint publications

Abhisheik Eedara

3 joint publications

Vaishnavi Kambhampati

2 joint publications

Bathini Nagendra Babu